RYTM
#1076
Rhythm Pharmaceuticals, Inc. - Common Stock
112.5 3 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.59%
Monthly Change
+4.56%
6 month change
+24.77%
Year Change
+2.01%
Previous Close
111.8 7
Open
112.5 3
Low
112.5 3
High
112.5 3
Volume
85
Financials
- Market Capitalization 7.75 B
- Employee 414
- Founded N/A
- CEO N/A
- Website www.rhythmtx.com
- Headquarter Delaware, United States
- FIGI BBG007DLZ601
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-34.42
Price to sales ratio
36.66
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1032 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.96 USD | +0.01% | +0.11% | +0.60% | +151.84% | 8.39 B USD | ||
| 1041 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.62 USD | +0.01% | -13.99% | -5.80% | +291.55% | 8.25 B USD | ||
| 1118 |  SRRK Scholar Rock Holding Corporation - Common Stock | 59.26 USD | -1.30% | +6.89% | +21.88% | +97.40% | 7.22 B USD | ||
| 1138 |  ERAS Erasca, Inc. - Common Stock | 19.49 USD | +1.78% | +12.79% | +8.28% | +1125.79% | 6.82 B USD |
Frequently asked questions about Rhythm Pharmaceuticals, Inc. Common Stock
What is the Rhythm Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) is 112.53. Over the past 24 hours, the stock has changed by +0.59%. Follow the RYTM chart for real-time price dynamics.
What is the stock ticker of Rhythm Pharmaceuticals, Inc. Common Stock?
Rhythm Pharmaceuticals, Inc. Common Stock trades under the ticker RYTM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rhythm Pharmaceuticals, Inc. Common Stock stock going up?
RYTM has changed by +2.88% over the last week, +4.56% over the last month, and +2.01% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Rhythm Pharmaceuticals, Inc. Common Stock?
Rhythm Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 7.75 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Rhythm Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Rhythm Pharmaceuticals, Inc. Common Stock reported earnings of -0.73 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Rhythm Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Rhythm Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 71.25 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Rhythm Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Rhythm Pharmaceuticals, Inc. Common Stock reported net income of -49.3 M for the last quarter. The previous quarter showed -55.64 M, which means net income changed by +11.40%.
How many employees does Rhythm Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Rhythm Pharmaceuticals, Inc. Common Stock has 414 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Rhythm Pharmaceuticals, Inc. Common Stock stock?
You can buy Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rhythm Pharmaceuticals, Inc. Common Stock stock?
Investing in Rhythm Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RYTM chart and related analysis on metatrader.com as part of your research.